NRAS and acral lentiginous melanoma: Furthermore, Taiwanese ALM patients were found to harbor the following mutations: BRAF (30%; V600E and V600L), NRAS (10%; G13R and G12D), MEK1 (5%; C121S), and PTEN (7.5%; Y315stop).